RB1, DEVELOPMENT, AND CANCER

被引:130
|
作者
Chinnam, Meenalakshmi [1 ]
Goodrich, David W. [1 ]
机构
[1] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA
来源
CANCER AND DEVELOPMENT | 2011年 / 94卷
关键词
RETINOBLASTOMA TUMOR-SUPPRESSOR; CYCLIN-DEPENDENT KINASES; DROSOPHILA FOLLICLE CELLS; TRANSCRIPTION FACTOR E2F; CONDITIONAL MOUSE MODEL; SKELETAL-MUSCLE CELLS; ELEGANS GERM-LINE; C-ELEGANS; IN-VIVO; CELLULAR SENESCENCE;
D O I
10.1016/B978-0-12-380916-2.00005-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The RB1 gene is the first tumor suppressor gene identified whose mutational inactivation is the cause of a human cancer, the pediatric cancer retinoblastoma. The 25 years of research since its discovery has not only illuminated a general role for RB1 in human cancer, but also its critical importance in normal development. Understanding the molecular function of the RB1 encoded protein, pRb, is a long-standing goal that promises to inform our understanding of cancer, its relationship to normal development, and possible therapeutic strategies to combat this disease. Achieving this goal has been difficult, complicated by the complexity of pRb and related proteins. The goal of this review is to explore the hypothesis that, at its core, the molecular function of pRb is to dynamically regulate the location-specific assembly or disassembly of protein complexes on the DNA in response to the output of various signaling pathways. These protein complexes participate in a variety of molecular processes relevant to DNA including gene transcription, DNA replication, DNA repair, and mitosis. Through regulation of these processes, RB1 plays a uniquely prominent role in normal development and cancer.
引用
收藏
页码:129 / 169
页数:41
相关论文
共 50 条
  • [1] Rb1 in sporadic colon cancer
    Ivkovic, T. Catela
    Cacev, T.
    Kapitanovic, S.
    EJC SUPPLEMENTS, 2010, 8 (05): : 197 - 197
  • [2] RB1 in cancer: Different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis
    Di Fiore, Riccardo
    D'Anneo, Antonella
    Tesoriere, Giovanni
    Vento, Renza
    JOURNAL OF CELLULAR PHYSIOLOGY, 2013, 228 (08) : 1676 - 1687
  • [3] Targeting RB1 status in cancer treatment
    Takahashi, Chiaki
    Sheng, Jindan
    Kohno, Susumu
    CANCER SCIENCE, 2022, 113
  • [4] New roles of Rb1 in expansion of MDSCs in cancer
    Youn, Je-In
    Gabrilovich, Dmitry I.
    CELL CYCLE, 2013, 12 (09) : 1329 - 1330
  • [5] RB1CC1 activates the promoter and expression of RB1 in human cancer
    Ikebuchi, Kaichiro
    Chano, Tokuhiro
    Ochi, Yasuko
    Tameno, Hitosuke
    Shimada, Taketoshi
    Hisa, Yasuo
    Okabe, Hidetoshi
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (04) : 861 - 867
  • [6] RB1, Cancer Lineage Plasticity and Therapeutic Resistance
    Zhang, Letian
    Goodrich, David W.
    ANNUAL REVIEW OF CANCER BIOLOGY, 2022, 6 : 201 - 221
  • [7] NuSAP is regulated by RB1 and modulates prostate cancer progression
    Gordon, Catherine A.
    Gong, Xue
    Gulzar, Zulfiqar G.
    Brooks, James D.
    CANCER RESEARCH, 2013, 73
  • [8] RB1 goes global
    Markus Wagner
    Nature Reviews Molecular Cell Biology, 2005, 6 : 282 - 282
  • [9] A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer
    Cetani, F
    Pardi, E
    Viacava, P
    Pollina, GD
    Fanelli, G
    Picone, A
    Borsari, S
    Gazzerro, E
    Miccoli, P
    Berti, P
    Pinchera, A
    Marcocci, C
    CLINICAL ENDOCRINOLOGY, 2004, 60 (01) : 99 - 106
  • [10] The Origin of the RB1 Imprint
    Kanber, Deniz
    Buiting, Karin
    Roos, Christian
    Gromoll, Joerg
    Kaya, Sabine
    Horsthemke, Bernhard
    Lohmann, Dietmar
    PLOS ONE, 2013, 8 (11):